Stanley C Erck - Net Worth and Insider Trading

Stanley C Erck Net Worth

The estimated net worth of Stanley C Erck is at least $97,665 dollars as of 2024-04-27. Stanley C Erck is the President and CEO of Novavax Inc and owns about 23,879 shares of Novavax Inc (NVAX) stock worth over $97,665. Details can be seen in Stanley C Erck's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Stanley C Erck has not made any transactions after 2021-10-04 and currently still holds the listed stock(s).

Transaction Summary of Stanley C Erck

To

Stanley C Erck Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Stanley C Erck owns 3 companies in total, including Novavax Inc (NVAX) , BioCryst Pharmaceuticals Inc (BCRX) , and MaxCyte Inc (MXCT) .

Click here to see the complete history of Stanley C Erck’s form 4 insider trades.

Insider Ownership Summary of Stanley C Erck

Ticker Comapny Transaction Date Type of Owner
NVAX Novavax Inc 2021-10-04 director & President and CEO
BCRX BioCryst Pharmaceuticals Inc 2008-12-22 director
MXCT MaxCyte Inc 2021-07-29 director

Stanley C Erck Latest Holdings Summary

Stanley C Erck currently owns a total of 1 stock. Stanley C Erck owns 23,879 shares of Novavax Inc (NVAX) as of October 4, 2021, with a value of $97,665.

Latest Holdings of Stanley C Erck

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
NVAX Novavax Inc 2021-10-04 23,879 4.09 97,665

Holding Weightings of Stanley C Erck


Stanley C Erck Form 4 Trading Tracker

According to the SEC Form 4 filings, Stanley C Erck has made a total of 5 transactions in Novavax Inc (NVAX) over the past 5 years, including 0 buys and 5 sells. The most-recent trade in Novavax Inc is the sale of 42,829 shares on October 4, 2021, which brought Stanley C Erck around $8 Million.

Insider Trading History of Stanley C Erck

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Stanley C Erck Trading Performance

GuruFocus tracks the stock performance after each of Stanley C Erck's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Stanley C Erck is 6.38%. GuruFocus also compares Stanley C Erck's trading performance to market benchmark return within the same time period. The performance of stocks bought by Stanley C Erck within 3 months outperforms 5 times out of 10 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Stanley C Erck's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Stanley C Erck

Average Return

37.29%

Average return per transaction

Outperforming Transactions

70%

7 out of 10 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 9.29 6.38 12.96 37.29 -7.42 4.52
Relative Return to S&P 500(%) 7.33 1.71 5.62 24.4 -18.33 -7.57

Stanley C Erck Ownership Network

Ownership Network List of Stanley C Erck

No Data

Ownership Network Relation of Stanley C Erck


Stanley C Erck Owned Company Details

What does Novavax Inc do?

Who are the key executives at Novavax Inc?

Stanley C Erck is the director & President and CEO of Novavax Inc. Other key executives at Novavax Inc include President & R&D Filip Dubovsky , President & R&D Gregory M Glenn , and EVP & Chief Strategy Officer Elaine O'hara .

Novavax Inc (NVAX) Insider Trades Summary

Over the past 18 months, Stanley C Erck made no insider transaction in Novavax Inc (NVAX). Other recent insider transactions involving Novavax Inc (NVAX) include a net purchase of 6,000 shares made by Gregory M Glenn ,

In summary, during the past 3 months, insiders sold 0 shares of Novavax Inc (NVAX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Novavax Inc (NVAX) were sold and 6,000 shares were bought by its insiders, resulting in a net purchase of 6,000 shares.

Novavax Inc (NVAX)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Novavax Inc Insider Transactions

No Available Data

Stanley C Erck Mailing Address

Above is the net worth, insider trading, and ownership report for Stanley C Erck. You might contact Stanley C Erck via mailing address: 20 Firstfield Road, #250, Gaithersburg Md 20878.

Discussions on Stanley C Erck

No discussions yet.